Linked Life Data

11773915

Source:http://linkedlifedata.com/resource/pubmed/id/11773915

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2002-1-4
pubmed:abstractText
The PlA2 polymorphism of the glycoprotein IIb/IIIa (fibrinogen) receptor has been associated with increased restenosis and stent thrombosis. We postulated that this allele could alter the antiplatelet effect of abciximab in patients undergoing percutaneous coronary intervention.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1097-6744
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
143
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
76-82
pubmed:dateRevised
2006-8-26
pubmed:meshHeading
pubmed:year
2002
pubmed:articleTitle
Reduced inhibition by abciximab in platelets with the PlA2 polymorphism.
pubmed:affiliation
Section of Cardiology, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1045, USA.
pubmed:publicationType
Journal Article